Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study

26 May 2022

Abstract excerpt

Abstract Background Existing clinical studies supported the potential efficacy of mesenchymal stromal cells as well as derived exosomes in the treatment of COVID-19. We aimed to explore the safety and efficiency of aerosol inhalation of the exosomes derived from human adipose-derived MSCs (haMSC-Exos) in patients with COVID-19. Methods The MEXCOVID trial is a phase 2a single-arm, open-labelled, interventional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatological and COVID-19 studies
Share to Extracellular vesicles in disease
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35619189
DOI: 10.1186/s13287-022-02900-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot studyPMID 35619189Read ↗

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity Read ↗

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity Read ↗

MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity Read ↗

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.Semantic proximity Read ↗

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read ↗

Stem-cell extracellular vesicles and lung repairSemantic proximity Read ↗

Mesenchymal Stromal Cells and Exosomes: Progress and ChallengesSemantic proximity Read ↗

Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Airway Inflammation in a Rat Model of chronic obstructive pulmonary disease (COPD)Semantic proximity Read ↗

Extracellular Vesicle-Enriched Secretome from Mesenchymal Stromal Cells Protects Against Chemically, Particulate-, and Ischemia-Induced Innate-Immunity Induced InflammationSemantic proximity Read ↗

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical TrialSemantic proximity Read ↗

Exosomes of different cellular origins: prospects and challenges in the treatment of acute lung injury after burnsSemantic proximity Read ↗

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.